Friday, July 19, 2024

Delistings outnumber IPOs by value in Hong Kong so far this year

CK Hutchison-controlled biopharmaceutical company Chi-Med applies to list  in Hong Kong | South China Morning Post 

 Delistings outnumber IPOs by value in Hong Kong so far this year

HONG KONG -- Depressed share prices and China's economic downturn trigger delistings in Hong Kong that far outweigh the value of companies going public.

As of the end of June, 14 Hong Kong-listed companies have announced moves to delist in the first half of the year. One has completed the process, in a deal worth $8.5 billion, according to Dealogic data. That is more than the $1.7 billion raised by 30 companies that went public during the same period.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.